Polycyclic compounds as lysophosphatidic acid receptor antagonists
US8664220B2 · kind B2 · utility
15Cited by
19References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2010 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Sep 29, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.